Quoin Pharmaceuticals, Ltd. (QNRX) › Operating Cash FlowQuoin Pharmaceuticals, Ltd. (QNRX) — Operating Cash FlowAnnual figures by period end, from SEC filings.2019-12-31: -$1.30M2020-12-31: -$1.34M2021-12-31: -$5.72M2022-12-31: -$8.48M2023-12-31: -$7.86M2024-12-31: -$7.86M2025-12-31: -$13.54M-$13.54M2019-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$13.54M—2026-03-26From 2025-01-012024-12-31-$7.86M—2026-03-26From 2024-01-012023-12-31-$7.86M—2025-03-13From 2023-01-012022-12-31-$8.48M—2024-03-14From 2022-01-012021-12-31-$5.72M—2023-03-15From 2021-01-012020-12-31-$1.34M—2022-04-14From 2020-01-012019-12-31-$1.30M—2022-04-14From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)